RXO, Inc.RXONYSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank32
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P32
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-42.86%
Q3 2025-170.00%
Q2 2025133.33%
Q1 2025-25.00%
Q4 2024-20.00%
Q3 2024-322.22%
Q2 2024175.00%
Q1 2024-185.71%
Q4 2023133.33%
Q3 2023-57.14%
Q2 2023180.00%
Q1 2023600.00%
Q4 2022-106.67%
Q3 2022-74.14%
Q2 202213.73%
Q1 2022-7.27%
Q4 202144.74%
Q3 2021-19.15%
Q2 2021-9.62%
Q1 20210.00%